Home LiteratureArticle Details
PMID: 1416820 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.

Antimicrobial agents and chemotherapy ·Vol. 36 ·No. 6 ·1992-06-00 ·Pages 1208-14

Anwar H, Strap JL, Chen K, Costerton JW

Abstract

The dynamic interaction of planktonic and biofilm cells of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin was investigated in a chemostat system. The results indicated that planktonic and young biofilm cells of the 2-day-old chemostat culture of P. aeruginosa were susceptible to killing by chemostat-controlled doses of either 250 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml or 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of the planktonic and young biofilm cells was observed after exposure of the cells to six chemostat-controlled doses of these antibiotic at 8-h intervals for 7 days. Regrowth of the organism was not observed after the termination of antibiotic therapy on day 7. A different picture was observed when antibiotic treatment was initiated on day 10 after inoculation. Viable old biofilm cells were reduced to approximately 20% after exposure to the chemostat-controlled doses of 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of old biofilm cells could not be achieved, and regrowth of the organism occurred after the termination of antibiotic therapy. These data suggest that young biofilm cells of mucoid P. aeruginosa can be effectively eradicated with the combination of piperacillin and tobramycin, while old biofilm cells are very resistant to these antibiotics and eradication of old biofilm cells is not achievable with the chemostat-controlled doses of piperacillin and tobramycin used in this study.

MeSH Terms
Culture Media Kinetics Piperacillin/pharmacology Pseudomonas aeruginosa/drug effects,growth & development Tobramycin/pharmacology
Chemicals
Culture Media Tobramycin Piperacillin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Anwar H
Department of Microbiology, University of Alberta, Edmonton, Canada.
Strap J L
Chen K
Costerton J W
References (19)
19 references, click to expand
  1. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.
    J Pediatr. 1986 May;108(5 Pt 2):800-5 PMID: 3009772
  2. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
    Infect Immun. 1980 May;28(2):546-56 PMID: 6772562
  3. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.
    Antimicrob Agents Chemother. 1985 Apr;27(4):619-24 PMID: 3923925
  4. Antibiotic penetration through bacterial capsules and exopolysaccharides.
    J Antimicrob Chemother. 1982 Nov;10(5):368-72 PMID: 6217183
  5. Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm.
    Antimicrob Agents Chemother. 1991 May;35(5):1008-10 PMID: 1906694
  6. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1990 Sep;34(9):1666-71 PMID: 2126686
  7. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.
    Clin Microbiol Rev. 1991 Apr;4(2):191-206 PMID: 1906371
  8. Testing the susceptibility of bacteria in biofilms to antibacterial agents.
    Antimicrob Agents Chemother. 1990 Nov;34(11):2043-6 PMID: 2073094
  9. Influence of interfaces on microbial activity.
    Microbiol Rev. 1990 Mar;54(1):75-87 PMID: 2181260
  10. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.
    J Gen Microbiol. 1989 May;135(5):1291-303 PMID: 2516117
  11. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.
    Antimicrob Agents Chemother. 1989 Oct;33(10):1824-6 PMID: 2511804
  12. Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation.
    J Antimicrob Chemother. 1989 Nov;24(5):647-55 PMID: 2513307
  13. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Can J Microbiol. 1985 Apr;31(4):387-92 PMID: 2988728
  14. Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
    Antimicrob Agents Chemother. 1986 May;29(5):765-8 PMID: 3089140
  15. Media for study of growth kinetics and envelope properties of iron-deprived bacteria.
    J Clin Microbiol. 1987 May;25(5):849-55 PMID: 3108311
  16. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
    J Infect Dis. 1985 Apr;151(4):575-80 PMID: 3919113
  17. Clinical significance of in vitro synergism between antibiotics in gram-negative infections.
    Antimicrob Agents Chemother. 1972 Dec;2(6):470-5 PMID: 4596743
  18. The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections.
    Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S867-73 PMID: 6419312
  19. Bacterial biofilms in nature and disease.
    Annu Rev Microbiol. 1987;41:435-64 PMID: 3318676
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1992-06-00
Pages
1208-14
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC190319
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]